Cencora Inc. logo

Cencora Inc. (ABG)

Market Closed
28 Jul, 20:00
XBER XBER
246. 00
+0.85
+0.35%
- Market Cap
- P/E Ratio
2.2% Div Yield
0 Volume
- Eps
245.15
Previous Close
Day Range
246 246
Year Range
197.8 271.4
Want to track ABG and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 7 days

Summary

ABG closed yesterday higher at €246, an increase of 0.35% from Friday's close, completing a monthly decrease of -2.3% or €5.8. Over the past 12 months, ABG stock gained 14.39%.
ABG pays dividends to its shareholders, with the most recent payment made on Jun 02, 2025. The next estimated payment will be in In 1 month on Sep 02, 2025 for a total of €0.55.
The last earnings report, released on Yesterday at 12:00 AM, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports. The next scheduled earnings report is due on Aug 06, 2025.
Cencora Inc. has completed 4 stock splits, with the recent split occurring on Jun 16, 2009.
The company's stock is traded on 8 different exchanges and in various currencies, with the primary listing on NYSE (USD).

ABG Chart

Chart

Chart with 60 data points.
The chart has 1 X axis displaying categories.
The chart has 2 Y axes displaying values, and values.
End of interactive chart.
Will Cencora (COR) Beat Estimates Again in Its Next Earnings Report?

Will Cencora (COR) Beat Estimates Again in Its Next Earnings Report?

Cencora (COR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks | 2 weeks ago
Here's Why You Should Add Cencora Stock to Your Portfolio Now

Here's Why You Should Add Cencora Stock to Your Portfolio Now

COR gains on strong GLP-1 and specialty drug growth, but margin pressure and fierce competition pose ongoing risks.

Zacks | 2 weeks ago
Here's Why You Should Add Cencora Stock to Your Portfolio Now

Here's Why You Should Add Cencora Stock to Your Portfolio Now

COR continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.

Zacks | 2 months ago

Cencora Inc. Dividends

Cencora Inc. logo
ABG 11 months ago
Other
€0.51 Per Share
Cencora Inc. logo
ABG 9 May 2024
Other
€0.51 Per Share
Cencora Inc. logo
ABG 8 Feb 2024
Other
€0.51 Per Share
Cencora Inc. logo
ABG 9 Nov 2023
Other
€0.51 Per Share
Cencora Inc. logo
ABG 10 Aug 2023
Other
€0.48 Per Share

Cencora Inc. Earnings

6 Aug 2025 (In 1 week) Date
3.82
Cons. EPS
-
EPS
29 Jul 2025 Date
-
Cons. EPS
-
EPS
7 May 2025 Date
-
Cons. EPS
-
EPS
29 Apr 2025 Date
-
Cons. EPS
-
EPS
29 Jan 2025 Date
-
Cons. EPS
-
EPS
Cencora Inc. logo
ABG 11 months ago
Other
€0.51 Per Share
Cencora Inc. logo
ABG 9 May 2024
Other
€0.51 Per Share
Cencora Inc. logo
ABG 8 Feb 2024
Other
€0.51 Per Share
Cencora Inc. logo
ABG 9 Nov 2023
Other
€0.51 Per Share
Cencora Inc. logo
ABG 10 Aug 2023
Other
€0.48 Per Share
6 Aug 2025 (In 1 week) Date
3.82
Cons. EPS
-
EPS
29 Jul 2025 Date
-
Cons. EPS
-
EPS
7 May 2025 Date
-
Cons. EPS
-
EPS
29 Apr 2025 Date
-
Cons. EPS
-
EPS
29 Jan 2025 Date
-
Cons. EPS
-
EPS

Cencora Inc. (ABG) FAQ

What is the stock price today?

The current price is €246.00.

On which exchange is it traded?

Cencora Inc. is listed on NYSE.

What is its stock symbol?

The ticker symbol is ABG.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 2.2%.

What is its market cap?

As of today, no market cap data is available.

What is the earnings per share?

The EPS is 3.82.

When is the next earnings date?

The next earnings report will release on Aug 06, 2025.

Has Cencora Inc. ever had a stock split?

Cencora Inc. had 4 splits and the recent split was on Jun 16, 2009.

Cencora Inc. Profile

Medical - Distribution Industry
Healthcare Sector
Robert P. Mauch PharmD CEO
XBER Exchange
US03073E1055 ISIN
US Country
42,000 Employees
14 Feb 2025 Last Dividend
16 Jun 2009 Last Split
- IPO Date

Overview

Cencora, Inc., previously known as AmerisourceBergen Corporation, represents a cornerstone in the pharmaceutical distribution industry. Established in 2001 and headquartered in Conshohocken, Pennsylvania, the company specializes in sourcing and distributing pharmaceutical products across various markets. Its operation spans a comprehensive array of services targeted at facilitating the accessibility and distribution of pharmaceuticals, healthcare products, and related services. Cencora's business operations are segmented into U.S. Healthcare Solutions and International Healthcare Solutions, each catering to a diverse range of customers and needs within the healthcare and pharmaceutical sectors.

Products and Services

U.S. Healthcare Solutions:

  • Distribution Services: Includes distributing pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a wide range of healthcare providers such as acute care hospitals, retail pharmacies, and mail order pharmacies.
  • Pharmacy Management and Consulting Services: Offers pharmacy management, staffing, supply management software, and consulting services to retail and institutional healthcare providers.
  • Packaging Solutions: Provides innovative packaging solutions to institutional and retail healthcare providers to ensure safety and efficiency in medication dispensing.
  • Support Services for Clinical Trials: Offers clinical trial support, product post-approval, and commercialization support services, coupled with data analytics and research services for biotechnology and pharmaceutical manufacturers.
  • Veterinary Products and Services: Distributes pharmaceuticals, vaccines, and other products for companion and production animals, along with providing sales force services to manufacturers.
  • Specialty Products and Services: Involves the distribution of plasma and other blood products, injectable pharmaceuticals, vaccines, and offers services to physicians specializing in various disease states, including oncology, hospitals, and dialysis clinics.

International Healthcare Solutions:

  • Pharmaceutical Wholesale and Related Service: Offers international pharmaceutical wholesale, distribution, and related services to pharmacies, doctors, health centers, and hospitals primarily in Europe.
  • Global Commercialization Services: Provides global commercialization services to enhance the reach and impact of pharmaceutical products across international markets.
  • Specialty Transportation and Logistics: Delivers specialty transportation and logistics services tailored for the biopharmaceutical industry, focusing on the secure and efficient delivery of pharmaceutical products.

Contact Information

Address: 1 West First Avenue
Phone: 610 727 7000